Researchers at the Hebrew University of Jerusalem have developed an innovative approach to fight antibiotic-resistant ...

Chimeric Therapeutics Ltd. (AU:CHM) has released an update. Chimeric Therapeutics, a leading Australian cell therapy company, has appointed Dr.

BioNTech has signed a definitive agreement to acquire Biotheus to obtain complete worldwide rights to BNT327/PM8002, a ...

Chardan Capital analyst Geulah Livshits reiterated a Buy rating on CARGO Therapeutics, Inc. (CRGX – Research Report) today and set a ...

Fate Therapeutics, Inc, a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer ...

Study: Beyond the blood: expanding CAR T cell therapy to solid tumors. Image Credit: Nemes Laszlo / Shutterstock In a recent ...

(MENAFN- Investor Brand Network) Tonix Pharmaceuticals (NASDAQ: TNXP) has published new data in mSphere demonstrating that TNX-801, a recombinant chimeric horsepox virus vaccine, shows significantly ...

DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...

A clinical trial showed CAR-T cell therapy may shrink aggressive brain and spinal cord tumours in young patients.

An immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant in a Stanford ...

Autolus Therapeutics has secured US Food and Drug Administration (FDA) approval for Aucatzyl (obecaktagene autoleucel), its ...

T-cell therapy is a revolutionary immunotherapy approach in which T cells are genetically modified to express a receptor that ...